MHA Keystone Center for Patient Safety & Quality. Frequently asked questions (FAQs) on central line-associated bloodstream infections (CLABSI). Available at: http://www.msic-online.org/pdf/BSI_Frequently_Asked_Questions.pdf Accessed July 5, 2009.
Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391-402. Abstract
Soufir L, Timsit JF, Mahe C, et al. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol. 1999;20:396-401. Abstract
CDC. Central Line-Associated Bloodstream Infection (CLABSI) Event. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf Date accessed: June 22, 2009.
O'Grady NP, Alexander M, Dellinger EP, et al. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR. 2002;51:1-26.
Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-1601. Abstract
Yokoe DS, Mermel LA, Andersen DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:s12-s21. Abstract
Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:s22-s30. Abstract
Klevens RM, Morrison MA, Nadle J, et al. Invasive methicllin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763-1771. Abstract
Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007. Am J Infect Control. 2008;36:609-626. Abstract
Rosenthal VD, Maki DG, Mehta A, et al. International nosocomial infection control consortium report, Data summary for 2002-2007. Am J Infect Control. 2008;36:627-637. Abstract
Trick WE, Zagorski BM, Tokars JI, et al. Computer algorithms to detect Bloodstream infections. Emerg Infect Dis. 2004;10:1612-1620. Abstract
Burton DC, Edwards JR, Horan TC, et al. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA. 2009;301:727-736. Abstract
Sifri CD. Healthcare epidemiology: quorum sensing: bacteria talk sense. Clin Infect Dis. 2008;47:1070-1076. Abstract
Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol. 2002;13:77-81. Abstract
Canadian Task Force on the Periodic Health Examination. The Periodic Health Examination. Can Med Assoc J. 1979;121:1193-1254. Abstract
Weinstein RA. SHEA consensus panel report: A smooth takeoff. Infect Control Hosp Epidemiol. 1998;19:91-93. Abstract
Timsit J-F, Schwebel C, Bouardma L, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults. A randomized controlled trial. JAMA. 2009;301:1231-1241. Abstract
Sanders J, Pithie A, Ganly P, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother. 2008;62:809-615. Abstract
Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: A systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81:1159-1171. Abstract
Institute for Healthcare Improvement. Implement the central line bundle. Available at: http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ImplementtheCentralLineBundle.htm. Accessed July 7, 2009
Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725-2732. Abstract

As an organization accredited by the ACCME, MedscapeCME requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

MedscapeCME encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author(s)

Robert A. Weinstein, MD

Professor of Internal Medicine, Rush Medical College, Chicago, Illinois; Interim Chairman, Department of Medicine, Cook County Hospital, Chicago, Illinois; Chief Operating Officer, Ruth M. Rothstein CORE Center, Chicago, Illinois

Disclosures

Disclosure: Robert A. Weinstein, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Sage Products Inc and US Centers for Disease Control and Prevention (CDC)
Served as an advisor or consultant for: CDC; Sage Products Inc; and Society for Healthcare Epidemiology of America
Served on the Board of Directors for: Infectious Diseases Society of America (IDSA)

Editor and Nurse Planner

Susan L. Smith, MN, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, reports no relevant financial interests or relationships.

CME/CE

An Evidence-Based Approach to the Prevention of Central Line-Associated Bloodstream Infections in Hospitalized Patients

Authors: Robert A. Weinstein, MD
CME/CE Released: 7/23/2009
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 7/23/2010

Start Activity

Target Audience and Goal Statement

This activity is intended for surgeons, infectious disease specialists, hospitalists, critical care specialists, emergency department physicians, physician assistants, and nurses/nurse practitioners who care for patients at risk for central line associated bloodstream infections.

The goal of this activity is to provide evidence-based information on prevention of catheter-related bloodstream infections, including central line associated bloodstream infections in hospitalized patients.

Upon completion of this activity, participants will be able to:

Recognize risk factors for central line-associated bloodstream infections (CLABSI) in hospitalized patients
Identify evidence-based best practices for insertion, care, and maintenance of central lines for prevention of CLABSI
Recognize components of the central line bundle used for prevention of CLABSI.

Disclosures

Author(s)

Robert A. Weinstein, MD

Professor of Internal Medicine, Rush Medical College, Chicago, Illinois; Interim Chairman, Department of Medicine, Cook County Hospital, Chicago, Illinois; Chief Operating Officer, Ruth M. Rothstein CORE Center, Chicago, Illinois

Disclosures

Disclosure: Robert A. Weinstein, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Sage Products Inc and US Centers for Disease Control and Prevention (CDC)
Served as an advisor or consultant for: CDC; Sage Products Inc; and Society for Healthcare Epidemiology of America
Served on the Board of Directors for: Infectious Diseases Society of America (IDSA)

Editor and Nurse Planner

Susan L. Smith, MN, PhD

Scientific Director, Medscape, LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, reports no relevant financial interests or relationships.

Accreditation Statements

For Physicians

MedscapeCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MedscapeCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

For Nurses

Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. MedscapeCME encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

From Medscape Education Infectious Diseases

CME/CE

An Evidence-Based Approach to the Prevention of Central Line-Associated Bloodstream Infections in Hospitalized Patients

Authors: Robert A. Weinstein, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME/CE Released: 7/23/2009

Valid for credit through: 7/23/2010

processing....

Skip Pre-Assessment »

Pre-Assessment: Measuring Educational Impact

To measure the effectiveness of this continuing education activity, please complete the following 2-question pre-test. The activity addresses these questions in the content that follows.

Page 1 of 8

CME/CE Information

References

Disclaimer

The material presented here does not necessarily reflect the views of MedscapeCME or companies that support educational programming on www.medscapecme.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

References

Faculty and Disclosures

Author(s)

Robert A. Weinstein, MD

Editor and Nurse Planner

Susan L. Smith, MN, PhD

CME/CE

An Evidence-Based Approach to the Prevention of Central Line-Associated Bloodstream Infections in Hospitalized Patients

Target Audience and Goal Statement

Disclosures

Author(s)

Robert A. Weinstein, MD

Editor and Nurse Planner

Susan L. Smith, MN, PhD

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

An Evidence-Based Approach to the Prevention of Central Line-Associated Bloodstream Infections in Hospitalized Patients

Pre-Assessment: Measuring Educational Impact